Toshiro Fujita

Active 1980–2024

200
Papers
37,691
Citations
110
h-index
198
i10-index

Citations

Citations per year for Toshiro Fujita1981: 4 citations1982: 1 citations1983: 2 citations1984: 3 citations1985: 3 citations1986: 3 citations1987: 6 citations1988: 2 citations1989: 6 citations1990: 2 citations1991: 5 citations1992: 1 citations1993: 2 citations1994: 11 citations1995: 1 citations1996: 3 citations1997: 6 citations1998: 29 citations1999: 44 citations2000: 113 citations2001: 148 citations2002: 193 citations2003: 282 citations2004: 325 citations2005: 436 citations2006: 396 citations2007: 447 citations2008: 498 citations2009: 514 citations2010: 541 citations2011: 444 citations2012: 526 citations2013: 445 citations2014: 377 citations2015: 343 citations2016: 311 citations2017: 265 citations2018: 270 citations2019: 939 citations2020: 916 citations2021: 819 citations2022: 567 citations2023: 420 citations2024: 589 citations2025: 263 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,457 citing papers, 29.6% of this breakdownJapan: 1,281 citing papers, 10.9% of this breakdownChina: 1,010 citing papers, 8.6% of this breakdownUnited Kingdom: 598 citing papers, 5.1% of this breakdownGermany: 553 citing papers, 4.7% of this breakdownCanada: 396 citing papers, 3.4% of this breakdownFrance: 384 citing papers, 3.3% of this breakdownItaly: 377 citing papers, 3.2% of this breakdownAustralia: 330 citing papers, 2.8% of this breakdownSpain: 234 citing papers, 2% of this breakdownNetherlands: 231 citing papers, 2% of this breakdownSwitzerland: 205 citing papers, 1.8% of this breakdown
0%29.6%Other 22.6%

Fields

  • Medicine58%
  • Biochemistry, Genetics and Molecular Biology29.3%
  • Immunology and Microbiology3.6%
  • Nursing3.6%
  • Neuroscience2.5%
  • Engineering0.9%
  • Other2.1%

Topics

  • Parathyroid Disorders and Treatments5.4%
  • Chronic Kidney Disease and Diabetes2.6%
  • Hormonal Regulation and Hypertension2.2%
  • Genetic Syndromes and Imprinting2%
  • Adipose Tissue and Metabolism1.9%
  • Magnesium in Health and Disease1.8%
  • Other84.1%

Coauthors

All papers

Open in search
  1. FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis

    Authors: , , , , , , , , , - Journal of Bone and Mineral Research 2004 cited by 1,870

  2. Klotho converts canonical FGF receptor into a specific receptor for FGF23

    Authors: , , , , , , , , - Nature 2006 cited by 1,846

  3. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

    Authors: , , , , , , , , - Journal of Clinical Investigation 2004 cited by 1,371

  4. PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Cell 1999 cited by 1,353

  5. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease

    Authors: , , , , , , , , - Nature Medicine 2008 cited by 448

  6. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II

    Authors: , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2004 cited by 680

  7. Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , - BMC Nephrology 2016 cited by 209

  8. Lactoferrin Suppresses Neutrophil Extracellular Traps Release in Inflammation

    Authors: , , , , , , , , , , , , , , , , - EBioMedicine 2016 cited by 165

  9. Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial

    Authors: , , , , , - The Lancet Diabetes & Endocrinology 2014 cited by 125

  10. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 1,457

  11. Podocyte as the Target for Aldosterone

    Authors: , , , , - Hypertension 2007 cited by 355

  12. Blockade of the Nuclear Factor-κB Pathway in the Endothelium Prevents Insulin Resistance and Prolongs Life Spans

    Authors: , , , , , , , , , , , , , - Circulation 2012 cited by 169

  13. Role of Rac1–mineralocorticoid-receptor signalling in renal and cardiac disease

    Authors: , - Nature Reviews Nephrology 2013 cited by 151

  14. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor–dependent pathway

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2011 cited by 232

  15. Salt causes aging-associated hypertension via vascular Wnt5a under Klotho deficiency

    Authors: , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 78

  16. Novel mechanisms of salt-sensitive hypertension

    Authors: , , , , - Kidney International 2023 cited by 33

  17. Renal L-Type Fatty Acid–Binding Protein in Acute Ischemic Injury

    Authors: , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2007 cited by 366

  18. Epigenetic modulation of the renal β-adrenergic–WNK4 pathway in salt-sensitive hypertension

    Authors: , , , , , , , , , , - Nature Medicine 2011 cited by 237

  19. The Role of Aldosterone in Obesity-Related Hypertension

    Authors: , - American Journal of Hypertension 2016 cited by 163

  20. Kidney and epigenetic mechanisms of salt-sensitive hypertension

    Authors: , - Nature Reviews Nephrology 2021 cited by 72

  21. Insulin Resistance, Obesity, Hypertension, and Renal Sodium Transport

    Authors: , , , , , - International Journal of Hypertension 2011 cited by 156

  22. Diabetes Induces Aberrant DNA Methylation in the Proximal Tubules of the Kidney

    Authors: , , , , , , , , , , , - Journal of the American Society of Nephrology 2015 cited by 113

  23. Salt-Sensitive Hypertension and the Kidney

    Authors: , , , - Hypertension 2024 cited by 63

  24. Cross-enhancement of ANGPTL4 transcription by HIF1 alpha and PPAR beta/delta is the result of the conformational proximity of two response elements

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Genome biology 2014 cited by 84